Nicotinamide Riboside in LVAD Recipients
Condition(s):Heart Failure,Congestive; Heart Failure New York Heart Association Class IV; Mitochondrial AlterationLast Updated:September 1, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Heart Failure,Congestive; Heart Failure New York Heart Association Class IV; Mitochondrial AlterationLast Updated:September 1, 2020Completed
Condition(s):Drug ToxicityLast Updated:January 19, 2024Recruiting
Condition(s):Heart Failure, SystolicLast Updated:November 16, 2022Completed
Condition(s):Diabetes Mellitus, Type 2; Kidney Failure, Chronic; HyperlipidemiaLast Updated:June 22, 2016Terminated
Condition(s):DyslipidemiaLast Updated:October 12, 2015Completed
Condition(s):Covid19; LymphopeniaLast Updated:November 8, 2021Completed
Condition(s):GlaucomaLast Updated:July 27, 2023Recruiting
Condition(s):Vascular Diseases; Kidney Disease; Blood Pressure; Oxidative StressLast Updated:March 14, 2023Recruiting
Condition(s):Discoid Lupus ErythematosusLast Updated:October 25, 2022Completed
Condition(s):Healthy VolunteersLast Updated:January 26, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.